Home / Treatments / Harvoni
Harvoni denials: what the review data shows
Independent reviewers have decided 614 published cases where an insurer denied Harvoni — and they overturned the insurer 85.3% of the time. A denial for Harvoni is a starting position, not a final answer.
Published decisions
614
2001–2026
Overturned
85.3%
524 denials reversed
By condition
Published outcomes when Harvoni was denied for these conditions.
| Condition | Decisions | Overturned |
|---|---|---|
| Hepatitis C | 406 | 87.4% |
| Hepatitis C Virus | 106 | 69.8% |
| Hepatitis_c | 66 | 90.9% |
| Hepatitis_c_virus | 22 | 100% |
How to use this in your appeal
These are outcomes from California’s external review program — an independent physician panel that binds the insurer. Every state has an equivalent process, and internal appeals succeed even more often. Cite the outcome record for Harvoniwhen you appeal: reviewers routinely find that denials like yours didn’t hold up.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY
Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.